At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 197 enrolled
Drug / intervention
Stannous fluoride +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
In Brief
A Phase 4 clinical trial evaluating Stannous fluoride and Sodium monofluorophosphate for Dentin Sensitivity. Completed, enrolled 197 participants across 1 site.
Detailed Summary
This single centre study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartOct 2016
Primary CompletionDec 2016
TodayJul 2026
First PostedOct 5, 2016
Enrollment StartOct 11, 2016
Primary CompletionDec 16, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.7 years ago
Interventions
Stannous fluorideother
0.454% weight by weight (w/w) stannous fluoride containing 1100 parts per million (ppm) fluoride
Sodium monofluorophosphateother
0.76% w/w sodium monofluorophosphate containing 1000 ppm fluoride